Skip to main content

Table 1 Clinical features of the four infants with PNDM

From: Permanent neonatal diabetes mellitus in China

 

Case 1

Case 2

Case 3

Case 4

At diagnosis

Age

14 days

37 days

2 months

38 days

Gender

F

M

M

M

Family history of diabetes

negative

negative

negative

negative

Birth weight

AGA

AGA

AGA

AGA

Blood glucose level (mmol/L)

39.0

48.5

27.0

40.0

HbA1c (%)

5.9

8.3

11.9

8.5

C-peptide (ng/mL)

0.31

0.20

0.25

0.57

Insulin level (mIU/L)

3.1

1.5

0.9

No data

DKA

yes

yes

no

yes

ABG

pH

7.114

7.250

7.330

6.911

Bicarbonate (mmol/L)

5.2

16.9

25.6

4.5

Pancreatic autoantibody

negative

negative

negative

negative

Urine

Urine sugar

4+

4+

3+

4+

Urine ketone

4+

4+

+/-

3+

Pancreas ultrasonography

normal

normal

normal

normal

Recent follow-up

Age

35 months

45 months

54 months

60 months

Insulin injections

CSII

MII

MII

MII

Insulin dosage

Humulin: basal 0.6 U/kg/dbolus 0.2 U/kg/d

Humulin: 0.7 U/kg/ day

Novolin 30R: 0.4 U/kg/ day

Humulin: 0.5 U/kg/day

Hypoglycemia/hyperglycemia

rare

few

sometimes

always

HbA1c (%)

6.7

7.1

8.0

10.5

Combine with other problems

Development delay

No

epilepsy

No

  1. PNDM, permanent neonatal diabetes mellitus; AGA, appropriate for gestational age; HbA1c, glycosylated hemoglobin; ABG, arterial blood gas; CSII, continuous subcutaneous insulin infusion; MII, multiple insulin injections; DKA, diabetic ketoacidosis.